✦ LIBER ✦

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

✍ Scribed by Francis Ka Leung Chan; Vincent Wai Sun Wong; Bing Yee Suen; Justin Che Yuen Wu; Jessica Yuet Ling Ching; Lawrence Cheung Tsui Hung; Aric Josun Hui; Vincent King Sun Leung; Vivian Wing Yan Lee; Larry Hin Lai; Grace Lai Hung Wong; Dorothy Kai Lai Chow; Ka Fa To; Wai Keung Leung; Philip Wai Yan Chiu; Yuk Tong Lee; James Yun Wong Lau; Henry Lik Yuen Chan; Enders Kwok Wai Ng; Joseph Jao Yiu Sung

Book ID: 117301168
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 128 KB
Volume: 369
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(07)60749-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TOCOX—A randomised, double-blind, placeb

TOCOX—A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk

✍ Katie M. Groom; Andrew H. Shennan; Bryony A. Jones; Paul Seed; Phillip R. Bennet 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

A comparison of aspirin and clopidogrel

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding

✍ Fei-Yuan Hsiao; Yi-Wen Tsai; Weng-Foung Huang; Yu-Wen Wen; Pei-Fen Chen; Po-Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB